论文部分内容阅读
抗血栓疗法包括口服或静脉应用抗凝药;随后又采用抗血小板药治疗由血小板引起的动脉系统血栓。后来找到了能直接溶解血凝块的溶血栓药,特别是尿激酶(UK)和链激酶(SK)。抗血栓疗法抗血栓疗法的目标是阻止凝血过程的发生。抗凝药:肝素是一个胃肠外应用的抗凝药,主要作用机理是结合于抗凝血酶Ⅲ,从而抑制凝血酶、凝血酶原和凝血激酶;它也可抑制由凝血酶引起的血小板聚集,并能抑制纤维蛋白稳定因子(凝血因子XⅢ)的活化。上述三种重要作用正是本品对活性血栓或栓塞疾病有效的原因。
Antithrombotic therapy includes oral or intravenous anticoagulation; followed by antiplatelet agents to treat platelet-derived arterial thrombosis. Later, thrombolytic drugs were found that directly dissolved blood clots, especially urokinase (UK) and streptokinase (SK). Antithrombotic therapy The goal of antithrombotic therapy is to stop the clotting process. Anticoagulant: Heparin is a parenteral anticoagulant that acts by binding to antithrombin III, thereby inhibiting thrombin, prothrombin and thrombin; it also inhibits thrombin-induced platelets Aggregation, and can inhibit the activation of fibrin stabilizing factor (factor XIII). The three important role is the product of active thrombosis or embolism disease causes effective.